BEUDAMED
    2 results · 10ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters Classification: Class Ii ×

    The THERAKOS CELLEX Photopheresis System is a photoimmune therapy. Catalog CLXUSA. Manufacturing lot D342 UDI: 20705030200003 The system designed to separate the patient's blood into various fractions and collect the white blood cell (WBC) fraction. The WBC fraction is treated with a photoactive drug UVADEX¿ (methoxsalen) Sterile Solution. The UVADEX is photo-activated by UVA light and results in the WBCs undergoing apoptosis

    FDA Enforcement
    Class II ·Terminated·Therakos Inc·April 13, 2016

    THERAKOS CELLEX Photopheresis Procedural Kit PRODUCT CODE: CLXUSA

    FDA Enforcement
    Class II ·Ongoing·Therakos, Inc.·November 17, 2021